NRAS and cancer: Mutations in the TERTprom lead to a 2-fold to 4-fold increase in the transcription of TERT, along with enhanced telomerase activity, and are often found in BRAFV600 and NRAS-mutant melanomas, where the combined alterations cooperate in boosting cancer progression and aggressiveness.